| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Iopamidol 510mg + iodine 250mg/mL (51%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 175mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 15mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 408mg/mL + iodine 200mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 75mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Radioiodine uptake study |
Using substance (attribute) |
False |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine poisoning |
Causative agent (attribute) |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iopamidol 755mg + iodine 370mg/mL (76%) injection solution 125mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 75mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 125mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 612mg + iodine 300mg/mL (61%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 175mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 408mg + iodine 200mg/mL (41%) injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Iopamidol 755mg/mL + iodine 370mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Free iodine (substance) |
Is a |
False |
Iodine |
Inferred relationship |
Some |
|
| Inorganic iodine |
Is a |
False |
Iodine |
Inferred relationship |
Some |
|
| Product containing iodine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine- and potassium iodide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing iodine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing iodine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Fetal iodine syndrome refers to symptoms and signs that may be observed in a fetus or newborn when the mother was exposed during pregnancy to inappropriate (insufficient or excessive) amounts of iodine. Iodine deficiency is associated with goiter and hypothyroidism. When severe iodine deficiency occurs during pregnancy, it is associated with congenital hypothyroidism that is manifested by increased neonatal morbi-mortality and severe mental dysfunction, hyperactivity, attention disorders and a substantial decrease of IQ of an irreversible nature. Excessive iodine ingestion during the third trimester of pregnancy can result in hypothyroidism and fetal goiter due to a prolonged inhibition of thyroid hormone synthesis, an increase in thyrotropin (TSH). |
Causative agent (attribute) |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Ethanol- and iodine- and potassium iodide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
2 |
| Increase or decrease in iodine content of the diet. |
Direct substance |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Increase in iodine content of the diet compared to the assessed baseline intake of iodine for the individual. |
Direct substance |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Decrease in iodine content of the diet compared to the assessed baseline intake of iodine for the individual. |
Direct substance |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Providing iodine based on suboptimal food or fluid intake, iatrogenic deficiency or medical diagnosis. |
Direct substance |
False |
Iodine |
Inferred relationship |
Some |
1 |
| Protein-bound iodine |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Iodine |
Inferred relationship |
Some |
|
| Product containing iodine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine compounds adverse reaction |
Causative agent (attribute) |
False |
Iodine |
Inferred relationship |
Some |
2 |
| Product containing iodine and isopropyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
2 |
| Iodine 0.7%/isopropyl alcohol 74% w/w topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iodine |
Inferred relationship |
Some |
|
| Product containing precisely iodine (as iotrolan) 2.4 gram/10 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Iodine |
Inferred relationship |
Some |
1 |
| Iododerma |
Causative agent (attribute) |
False |
Iodine |
Inferred relationship |
Some |
1 |
| Exposure to iodine |
Causative agent (attribute) |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Ethanol and iodine and potassium iodide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
2 |
| Product containing only iodine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine and isopropyl alcohol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
2 |
| Product containing only iodine and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
2 |
| Iodine and potassium iodide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine and potassium iodide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as iotrolan) 240 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Allergic contact dermatitis caused by iodine (disorder) |
Causative agent (attribute) |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as povidone iodine) 100 mg/g vaginal gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| The approximate quantity of intake in one day of iodine. |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Iodine |
Inferred relationship |
Some |
6 |
| Contact dermatitis caused by iodine (disorder) |
Causative agent (attribute) |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine intake (observable entity) |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Iodine |
Inferred relationship |
Some |
2 |
| The known quantity of intake of iodine from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Iodine |
Inferred relationship |
Some |
5 |
| Estimated quantity of iodine needed for nutritional adequacy in one day. |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Iodine |
Inferred relationship |
Some |
4 |
| Administration of prophylactic iodine for iodine deficiency goitre |
Direct substance |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing precisely iodine (as iopromide) 370 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing precisely iodine (as iopromide) 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as iopromide) 240 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing precisely iodine (as iopamidol) 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing precisely iodine (as iopamidol) 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as iopamidol) 370 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as iomeprol) 350 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as iomeprol) 400 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as iomeprol) 300 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as iomeprol) 250 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as iohexol) 350 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as iohexol) 240 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing precisely iodine (as iohexol) 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as iodixanol) 270 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing precisely iodine (as iodixanol) 320 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing precisely iodine (as iopamidol) 340 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine 50 mg/mL and potassium iodide 100 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine 50 mg/mL and potassium iodide 100 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing iodine and potassium iodide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing only iodine and potassium iodide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| The approximate quantity of intake in one day of iodine. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Iodine |
Inferred relationship |
Some |
3 |
| Iodine intake (observable entity) |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Iodine |
Inferred relationship |
Some |
2 |
| The known quantity of intake of iodine from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Iodine |
Inferred relationship |
Some |
5 |
| Product containing precisely iodine 25 milligram/1 milliliter and potassium iodide 25 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing precisely iodine 25 milligram/1 milliliter and potassium iodide 25 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Product containing precisely iodine (as iotroxate meglumine) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as ethiodized oil) 190 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine (as ethiodised oil) 480 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Estimated quantity of iodine needed for nutritional adequacy in one day. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Iodine |
Inferred relationship |
Some |
4 |
| The approximate quantity of intake in one day of iodine. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Estimated quantity of iodine needed for nutritional adequacy in one day. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| Iodine intake (observable entity) |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Iodine |
Inferred relationship |
Some |
1 |
| The known quantity of intake of iodine from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Iodine |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]